(Q48598672)

13 February 2018

title

Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. (English)

1 reference

13 February 2018

0 references

0 references

Gurley BJ

1

1 reference

13 February 2018

Swain A

2

1 reference

13 February 2018

Hubbard MA

3

1 reference

13 February 2018

Hartsfield F

4

1 reference

13 February 2018

Thaden J

5

1 reference

13 February 2018

Williams DK

6

1 reference

13 February 2018

Gentry WB

7

1 reference

13 February 2018

Tong Y

8

1 reference

13 February 2018

language of work or name

English

0 references

publication date

9 May 2007

1 reference

13 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

13 February 2018

volume

83

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

61-69

1 reference

13 February 2018

Increasing trends in elderly persons' use of nonvitamin, nonmineral dietary supplements and concurrent use of medications

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Factors associated with dietary supplement use among prescription medication users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Herbal interactions involving cytochrome p450 enzymes: a mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Pharmacokinetic interactions between herbal remedies and medicinal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Interactions of herbs with cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Inhibition of human cytochrome P450 activities by kava extract and kavalactones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Composition and biological activity of traditional and commercial kava extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Influence of Goldenseal Root on the Pharmacokinetics of Indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

In vitro approaches to predicting drug interactions in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Kinetics of kavain and its metabolites after oral application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Phytochemical Assays of Commercial Botanical Dietary Supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

High-performance liquid chromatography determination of hydrastine and berberine in dietary supplements containing goldenseal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

7 January 2021

Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

7 January 2021

The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

7 January 2021

Identification of some human urinary metabolites of the intoxicating beverage kava

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100222

1 reference

13 February 2018

1 reference

13 February 2018